HK Stock Market Move | EXTREME VISION (06636) rose more than 6%, with its large model business becoming the main revenue engine. The company is expected to be included in the Hong Kong Stock Connect list.
Extreme Perspective (06636) rose over 6%. As of the time of writing, it has increased by 6.37%, trading at HK$88.55, with a transaction volume of HK$11.36 million.
EXTREME VISION (06636) rose over 6%, as of the report, up 6.37% at HKD 88.55, with a transaction volume of HKD 11.36 million.
In terms of news, EXTREME VISION reported revenue of 165 million yuan in the first half of this year, an increase of 181.2% year-on-year; the loss attributable to shareholders of the parent company was 40.831 million yuan, a decrease of 3.92% year-on-year. The explosive growth in revenue mainly comes from the accelerated commercialization of large model solutions, which generated revenue of 84.8 million yuan, a staggering increase of 4539.8% compared to the same period last year. The number of clients for the company's large model solutions has increased to 16, driving rapid revenue growth in this business line.
In addition, EXTREME VISION has been included in the Hang Seng Composite Index, with the changes to be implemented after market close on September 4 and effective from September 7. At that time, the Shanghai and Shenzhen exchanges will adjust the range of investable stocks for the Hong Kong Stock Connect accordingly. EXTREME VISION may be added to the Hong Kong Stock Connect, as it meets a series of criteria including market capitalization and liquidity.
Related Articles

How to choose AI applications in Hong Kong stocks? DIAGENS-B (02526): A rare vertical AI target with high growth and strong barriers.

Valuation at $2 trillion! Anthropic may become the largest IPO in history, starting its roadshow in October and going public before the mid-term elections in November.

Astrazeneca PLC Sponsored ADR (AZN.US) has received accelerated approval from the FDA for a new breast cancer drug, and Wall Street estimates that sales could reach $2.3 billion by 2032.
How to choose AI applications in Hong Kong stocks? DIAGENS-B (02526): A rare vertical AI target with high growth and strong barriers.

Valuation at $2 trillion! Anthropic may become the largest IPO in history, starting its roadshow in October and going public before the mid-term elections in November.

Astrazeneca PLC Sponsored ADR (AZN.US) has received accelerated approval from the FDA for a new breast cancer drug, and Wall Street estimates that sales could reach $2.3 billion by 2032.

RECOMMEND





